MedTech Dealmakers October 2015

Medtech Dealmakers is a first-of-its-kind partnering supplement to Nature Biotechnology, Nature Medicine and Nature Reviews Drug Discovery exploring the dealmaking trends of the growing medical technology industry. With reviews of the partnering landscape and a showcase of innovative companies seeking partners, this is a new must-read publication for medical technology professionals.

Oct 15, 2015
2
0

Read the first edition of MedTech Dealmakers

Read about the companies working in the medical technology industry and looking for partnerships from our first medtech edition -

Lohmann & Rauscher

BTG

The University of Tokyo

Histide AG

NuGEN Technologies Inc

DNAnexus

InvivoSciences

Biocartis

Pacific Edge

Read the in-depth partnering features from our first medtech edition -

Key drivers in the medical technology deal landscape

Genomics technologies march into new markets

Precision medicine’s invigorating effect on cancer medical technology

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.